The Food and Drug administration has cleared GE Healthcare's AdvantageALA, lung analysis software technology for CT used to evaluate lung nodules and other lesions.
Waukesha, WI-based GE said AdvantageALA also features a new digital contrast agent that will automatically highlight suspicious anatomical regions such as lung nodules.
By AuntMinnie.com staff writers
November 30, 2004
Related Reading
GE's RSNA advances include 64-slice PET/CT, HDMR, November 28, 2004
GE, Maquet in MR-guided surgery collaboration, November 24, 2004
GE notches Hawkeye mark, November 24, 2004
Road to RSNA, GE Healthcare, November 10, 2004
Copyright © 2004 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)